4//SEC Filing
Ahn Edward S. 4
Accession 0001171843-18-001659
CIK 0000898437other
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 4:07 PM ET
Size
6.1 KB
Accession
0001171843-18-001659
Insider Transaction Report
Form 4
Ahn Edward S.
Chief Tech. & Strategy Officer
Transactions
- Award
Stock Option (Right to Buy)
2018-03-02+7,788→ 7,788 totalExercise: $50.13Exp: 2027-01-27→ Common Stock (7,788 underlying)
Footnotes (3)
- [F1]The exercise price of the stock options represents the closing price of the Company's common stock on the grant date, January 27, 2017, the date the Compensation Committee of the Company granted these performance-based stock option awards (the "Performance Grant"). Please also see notes 2 and 3.
- [F2]On March 2, 2018, the Compensation Committee determined and certified that 55% of the initial Performance Grant had been earned, subject to time-based vesting. Please also see notes 1 and 3.
- [F3]The stock options vest in three equal installments on the following dates: March 2, 2018, January 1, 2019, and January 1, 2020.
Documents
Issuer
Anika Therapeutics, Inc.
CIK 0000898437
Entity typeother
Related Parties
1- filerCIK 0001623597
Filing Metadata
- Form type
- 4
- Filed
- Mar 1, 7:00 PM ET
- Accepted
- Mar 2, 4:07 PM ET
- Size
- 6.1 KB